Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the MRC Weatherall Institute of Molecular Medicine have developed a new platform based on CRISPR/Cas9 technology, to alter the way human cells respond to external signals.

Cells are constantly monitoring the environment around them and are programmed to respond to molecular cues in their surroundings in distinct ways – some cues may prompt cells to grow, some lead to cell movement and others initiate cell death. For a cell to remain healthy, these responses must be finely balanced. It took evolution over two billion years to tune these responses and orchestrate their interplay in each and every human cell. But what if we could alter the way our cells respond to certain aspects of their environment? Or make them react to signals that wouldn’t normally provoke a reaction? New research published by scientists at the MRC WIMM takes cellular engineering to the next level in order to achieve just that.

In a paper published in Cell Reports, graduate student Toni Baeumler and Associate Professor Tudor Fulga (Radcliffe Department of Medicine) have used a derivative of the CRISPR/Cas9 technology to rewire the way cells respond to extracellular signals. CRISPR/Cas9 frequently makes the headlines as it allows medical researchers to accurately manipulate the human genome – opening up new possibilities for treating diseases. These studies often focus on correcting faulty genes in crops, livestock, mammalian embryos or cells in a dish. However, not all diseases are caused by a defined error in the DNA. In more complex disorders like diabetes and cancer, it may be necessary to completely rewire the way in which cells work.

Read more on the Oxford Science Blog.

Similar stories

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Anjali Kusumbe receives Women in Cell Biology Early Career Medal

Founded in 2015 to mark the 50th anniversity of the founding of the British Society for Cell Biology, the award recognises outstanding early career biologists.

Asger Jakobsen receives ASH-BSH Abstract Achievement Award

Dr Jakobsen, a Clinical Research Fellow and DPhil student from the Vyas Group has received the award from the American Society of Hematology and the British Society of Haematology.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

2022 RDM Graduate Prize Winners

This year's RDM winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.